Advanced search
Publication Cover
Drug Delivery Volume 9, 2002 - Issue 1
Submit an article Journal homepage
167
Views
27
CrossRef citations to date
0
Altmetric
Research Article

Bacopasaponin C: Critical Evaluation of Anti-Leishmanial Properties in Various Delivery Modes

J. Sinha Biomembrane Division, Indian Institute of Chemical Biology, Calcutta, India
,
B. Raay Biomembrane Division, Indian Institute of Chemical Biology, Calcutta, India
,
N. Das Biomembrane Division, Indian Institute of Chemical Biology, Calcutta, India
,
S. Medda Biomembrane Division, Indian Institute of Chemical Biology, Calcutta, India
,
S. Garai Biomembrane Division, Indian Institute of Chemical Biology, Calcutta, India
,
S. B. Mahato Biomembrane Division, Indian Institute of Chemical Biology, Calcutta, India
&
M. K. Basu Biomembrane Division, Indian Institute of Chemical Biology, Calcutta, India
 show all
Pages 55-62 | Published online: 29 Sep 2008

  • Allerman, E., Gurny R., and Doelker, E. 1993. Drug loaded nanoparticules : Preparation, methods and drug targeting tissues. Eur. J. Pharm. Biopharm. 39:173-191.
  • Anderson, J. M., and Shive, M. S. 1997. Biodegradation and biocompatibility of PLA and PLGA microsphere. Adv. Drug. Del Rev. 28:5-24.
  • Baillie, A. J., Florence, A. T., Hume, L., Muirhead G. T., and Rogerson, A. 1985. The preparation and properties of niosomes-non-ionic surfactant vesicles. J. Pharm. Pharmacol. 37:863-868.
  • Davis, S. S., and Illum, L. 1988. Polymeric microspheres as drug carriers. Biomaterials 9:111-115.
  • Davis, S. S., Illum, L., Mognimi, S. M., Davies, M. C., Porter, C. J. H., Muir, I. S., Brindley, A., Christy, N. M., Norman, M. E., Williums, P., and Dunn, S. E. 1993. Microspheres for targeting drugs to specific body sites. J. Cont. Release 24:157-163.
  • Delmas, F., Giorgio, C., Elias, D. R., Gasquet, M., Azas, N., Mshvildadze, V., Dekanosidze, G., Kemertelidze, E., and David, P. T. 2000. Antileishmanial activity of three saponins isolated from ivy, alpha ederin, beta hederin and hederacol chiside AI, as compared to their action on mammalian cells cultured in vitra Planta Medico 66(4):343-347.
  • Dutta, A. K., Bhaumik, D., and Chatterjee, R. 1987. Isolation and characterization of Adenosine Kinase from Leishmani a donovani. J. Biol. Chem. 262 (12): 5515-5521.
  • Garai, S., Mahato, S. B., Ohtani, K., and Yamasaki, K. 1996. Damnarane type triterpenoid saponins from Bacopamonniera. Phytochemistry 42(3):815-820.
  • Gref, R., Domb, A., Quelle, P., Blunk, T., Muller, R. H., Verbatz, J. M., and Langer, R. 1995. Controlled intervenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv. Drug Del Rev. 16:215-233.
  • Gregoriadis, G., and Ryman, B. E. 1972. Lysosomal, localization of fracto furanosidase containing liposomes injected into rats. Biochem. J. 129: 123-137.
  • Guerrero, D. Q., Allemann, E., Fessi, H., and Doelker, E. 1998. Preparation Techniques and mechanism of formation of Biodegradable Nanoparticles from preformed polymers. Drug Dev. Ind. Pharmacy 24(12): 1113-1128.
  • Gurr, E. 1962. Staining, animal tissues practical and theoretical. London: Leonard Hill.
  • Guterres, S. S., Fessi, H., Barratt, G., Devissaguet J. P., and Puisieux, F. 1995. Poly (DL-lactide) nanocapsules containing diclofenac: I. Formulation and stability study. Int. J. Pharm. 113:57-63.
  • Hiremath, S. R., and Hota, A. 1999. Nanoparticles as drug delivery systems. Indian J. Pharm. 61 (2):69-75.
  • Kind, P. R. N., and King, E. J. 1954. Estimation of plasma phosphatese by determination of hydrolysed phenol with amino antipyrine. J. Clin. Path. 7: 322-326.
  • Kreuter, J. 1996. Nanoparticles and microparticles for drug and vaccine delivery. J.Anat. 189(Pt.3):503-505.
  • Majhi, P. R., and Moulik, S. P. 1999. Microcalorimetric investigations of AOT self-association in oil and state of pool water in water/oil microemulsions. J. Phys. Chem. 103:5977-5983.
  • Moulik, S. P., De, G. C., Panda, A. K., Bhowmick B. B., and. Das, A. R. 1999. Disperse molecular aggregates, 1. Synthesi s and characterization of nanoparticles of Cu2 [Fe(CN)6] in H2O/AOT/W- heptane water-in-oil microemulsion media. Langmuir 15:8361-8367.
  • Otshudi, A. L., Foriers, A., Vercruysse, A., Zeebroeck, A. V., and Lauwers, S. 2000. In vitro antimicrobiol treatment of dysentery and diarrhoea in Democratic Republic of Congo (DRC). Phytomedicine 7(2): 167-172.
  • Ray, S., Hazra, B., Mittra, B., Das, A., Mazumder, H. K., and Diospyrin, A. 1998. Bisnaphthoquinone: A novel inhibitor of Type I DNA topoisomerase leishmania donovani. MoI. Pharmacol. 54:994-999.
  • Reitman, S., and Frenkel, S. A. 1957. Colorimetric method for the determination of serum glutamic oxalacetic acid and glutamic pyruvic transaminase. Am. J. Clin. Path. 28:53-56.
  • Seyler, I., Morin, C., Barratt, G. Appel, M., Devissaguet, J. P., and Puisieux, F. 1995. Induction of macrophage NO-synthase by an immunomodulator entrapped within polymeric nanocapsules. Eur. J. Pharm. Biopharm. 41 (1):4954.
  • Stauber, L. A., Franchi no, E., and Grun, J. 1958. An eight-day method for screening compound against Leishmania donovani in golden hamster. J. Protozool. 5:263-273.
  • Stolnik, S., Ilium, L., and Davis, S. S. 1995. Long circulating microparticulate drug carrier. Adv. Drug Del Rev. 16:195-214.
  • Torchilin, V. P., and Trubetskoy, V. S. 1995. Which polymers can make nanoparticulate drug carriers long circulating. Adv. Drug Del. Rev. 16:141-145.
  • Traore, F., Faure, R., Olliver, E., Gasquet, M., Azas, N., Debrauwer, L., Keita, A., David, P. T., and Balansard, G. 2000. Structure and antiprotozoal activity of triterpenoid saponins from Glinus oppositifolius. Planta Medico 66(44): 368-371.
  • Wang, Min Ya., Sato, H., Adachi I., and Horikoshi, I. 1996. Preparation and characterization of poly (lactic-co-glycolic acid) microspheres for targeted delivery of novel anticancer agent. Taxol. Chem. Pharm. Bull. 44(10):19351940.
  • Yoshioka, T., Sternberg B., and Florence, A. T. 1994. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (span 20, 40, 60 and 80) and sorbitan triesters (span 85). Int. J. Pharm. 105:1-6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.